Imperial College London

ProfessorSimakAli

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Molecular Endocrine Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2811simak.ali

 
 
//

Location

 

133ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Clark:2017,
author = {Clark, K and Ainscow, E and Peall, A and Thomson, S and Leishman, A and Elaine, S and Ali, S and Coombes, R and Barrett, A and Bahl, AK},
publisher = {AMER SOC HEMATOLOGY},
title = {CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432419406278&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Clark,K
AU - Ainscow,E
AU - Peall,A
AU - Thomson,S
AU - Leishman,A
AU - Elaine,S
AU - Ali,S
AU - Coombes,R
AU - Barrett,A
AU - Bahl,AK
PB - AMER SOC HEMATOLOGY
PY - 2017///
SN - 0006-4971
TI - CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432419406278&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -